These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11921427)

  • 1. Development of oral insulin: progress and current status.
    Gordon Still J
    Diabetes Metab Res Rev; 2002; 18 Suppl 1():S29-37. PubMed ID: 11921427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist System.
    Modi P; Mihic M; Lewin A
    Diabetes Metab Res Rev; 2002; 18 Suppl 1():S38-42. PubMed ID: 11921428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of clinical trials: update on oral insulin spray formulation.
    Pozzilli P; Raskin P; Parkin CG
    Diabetes Obes Metab; 2010 Feb; 12(2):91-6. PubMed ID: 19889002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technosphere insulin technology.
    Richardson PC; Boss AH
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S65-72. PubMed ID: 17563306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
    Morishita M; Goto T; Nakamura K; Lowman AM; Takayama K; Peppas NA
    J Control Release; 2006 Feb; 110(3):587-94. PubMed ID: 16325951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Co-administration of intranasally delivered insulin and proinsulin C-peptide to rats with the types 1 and 2 diabetes mellitus restores their metabolic parameters.].
    Derkach KV; Bondareva VM; Shpakov AO
    Adv Gerontol; 2017; 30(6):851-858. PubMed ID: 29608829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Insulin: Myth or Reality.
    Kumar V; Choudhry I; Namdev A; Mishra S; Soni S; Hurkat P; Jain A; Jain D
    Curr Diabetes Rev; 2018; 14(6):497-508. PubMed ID: 28637407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.
    Owens DR
    Diabet Med; 1998; 15 Suppl 4():S28-36. PubMed ID: 9868989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral insulin - a review of current status.
    Iyer H; Khedkar A; Verma M
    Diabetes Obes Metab; 2010 Mar; 12(3):179-85. PubMed ID: 20151994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulins today and beyond.
    Owens DR; Zinman B; Bolli GB
    Lancet; 2001 Sep; 358(9283):739-46. PubMed ID: 11551598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology to inform insulin dose adjustments: its time is near.
    Zisser HC
    Diabetes Technol Ther; 2012 Aug; 14(8):649-50. PubMed ID: 22853718
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
    Chalasani KB; Russell-Jones GJ; Jain AK; Diwan PV; Jain SK
    J Control Release; 2007 Sep; 122(2):141-50. PubMed ID: 17707540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.
    Owens DR; Luzio SD; Ismail I; Bayer T
    Diabetes Care; 2000 Apr; 23(4):518-23. PubMed ID: 10857945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatrics, Pens, and Pumps.
    Hieronymus L; Hepner A; Cherolis J
    Diabetes Self Manag; 2015; 32(2):20-3. PubMed ID: 26665831
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug Delivery Systems for Diabetes Treatment.
    Zaric BL; Obradovic M; Sudar-Milovanovic E; Nedeljkovic J; Lazic V; Isenovic ER
    Curr Pharm Des; 2019; 25(2):166-173. PubMed ID: 30848184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy in type 2 diabetes.
    Mudaliar S; Edelman SV
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.